[Estrogen decreases vascular damage induced by chronic hypoperfusion through upregulating VEGF expression]

Area of Science:

• Neuroscience
• Endocrinology
• Vascular Biology

Background:

• Vascular dementia is a debilitating condition often caused by reduced blood flow to the brain.
• Cerebral chronic hypoperfusion leads to significant vascular damage and cognitive impairment.
• Estrogen replacement therapy is being investigated for its neuroprotective potential.

Purpose of the Study:

• To investigate the therapeutic effects of 17-β-estradiol (E2) on vascular dementia induced by chronic cerebral hypoperfusion.
• To assess the impact of E2 on vascular integrity and the expression of vascular endothelial growth factor (VEGF).

Main Methods:

• A rat model of bilateral common carotid artery occlusion (BCCAO) was used to induce chronic hypoperfusion.
• E2 treatment was administered at different time points post-BCCAO.
• Vascular damage (IgG leakage), microvascular ultrastructure, and VEGF expression were analyzed.

Main Results:

• BCCAO induced significant vascular damage, including IgG leakage and endothelial cell injury, evident up to 3 months.
• E2 treatment significantly reduced vascular damage and improved microvascular ultrastructure.
• E2 therapy increased VEGF expression, which was reduced by BCCAO.

Conclusions:

• Early and sustained vascular structural damage occurs following cerebral hypoperfusion.
• Physiological dose E2 replacement therapy demonstrates neuroprotective effects against vascular dementia.
• E2 may exert its beneficial effects by up-regulating VEGF expression and preserving vascular integrity.